Detalhe da pesquisa
1.
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
BMC Neurol
; 19(1): 167, 2019 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319804
2.
Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients.
Clin Chem Lab Med
; 55(10): 1621-1629, 2017 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28282291
3.
Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.
BMC Neurol
; 15: 228, 2015 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545730
4.
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
BMC Neurol
; 15: 111, 2015 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26162891
5.
Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.
Int J Mol Sci
; 16(6): 12147-58, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26030673
6.
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Crit Care
; 13(5): R158, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19799791
7.
Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.
World Neurosurg
; 126: e1537-e1541, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926559
8.
High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.
World Neurosurg
; 132: e630-e636, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442656
9.
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.
J Crit Care
; 51: 117-121, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802757
10.
Serum caspase 3 levels are associated with early mortality in severe septic patients.
J Crit Care
; 34: 103-6, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27288619
11.
The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.
PLoS One
; 10(6): e0129565, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066833
12.
Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
PLoS One
; 10(3): e0121739, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25822281
13.
Serum melatonin levels are associated with mortality in severe septic patients.
J Crit Care
; 30(4): 860.e1-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869726
14.
Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study.
PLoS One
; 9(10): e109618, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25290885
15.
Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients.
Thromb Res
; 134(1): 182-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814968
16.
Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
Thromb Res
; 134(4): 832-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123332
17.
Red blood cell distribution width during the first week is associated with severity and mortality in septic patients.
PLoS One
; 9(8): e105436, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25153089
18.
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
PLoS One
; 9(4): e94318, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24727739
19.
Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
PLoS One
; 9(4): e94370, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24728097